Trulicity 0.75 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJTC3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,396
Award facts
- Contract value 100% obligated
- $23,396.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a contract ceiling value of $23,396.32. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The order is scheduled for ultimate completion by September 18, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a prescription diabetes medication, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support defense healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, demonstrates significant capability in fulfilling federal medical supply requirements through competitive procurement, with an extensive portfolio spanning specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJTC3?
SPE2DB25FJTC3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJTC3 worth?
The government has obligated $23,396 on SPE2DB25FJTC3.
Is contract SPE2DB25FJTC3 an order under another contract?
Yes. SPE2DB25FJTC3 is a delivery order under SPE2DB22D2005, an indefinite delivery contract.
Was contract SPE2DB25FJTC3 competed?
The extent of competition for SPE2DB25FJTC3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award